Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment.
about
Is personality a key predictor of missing study data? An analysis from a randomized controlled trialAssessing and reporting heterogeneity in treatment effects in clinical trials: a proposalTailoring of self-management interventions in patients with heart failureUsing group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence.Early mortality of alcoholic hepatitis: a review of data from placebo-controlled clinical trialsAssessing Heterogeneity of Treatment Effects: Are Authors Misinterpreting Their Results?Individualized cost-effectiveness analysis.From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primerPlacebo in nonalcoholic steatohepatitis: insight into natural history and implications for future clinical trialsA CTSA agenda to advance methods for comparative effectiveness research.An analysis of common ethical justifications for compassionate use programs for experimental drugsMeasuring quality of care in patients with multiple clinical conditions: summary of a conference conducted by the Society of General Internal Medicine.Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research.Is treatment heterogeneity an Achilles' heel for comparative effectiveness research?Bench-to-bedside review: the initial hemodynamic resuscitation of the septic patient according to Surviving Sepsis Campaign guidelines--does one size fit all?Comparative effectiveness and the future of clinical research in diabetesUnderstanding heterogeneity in response to antidiabetes treatment: a post hoc analysis using SIDES, a subgroup identification algorithm.What ever happened to N-of-1 trials? Insiders' perspectives and a look to the futureDealing with heterogeneity of treatment effects: is the literature up to the challenge?Informing clinical practice guideline development and implementation: prevalence of coexisting conditions among adults with coronary heart diseaseSingle-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research.A comprehensive review of predictive and prognostic composite factors implicated in the heterogeneity of treatment response and outcome across disease areas.Comprehensive review of factors implicated in the heterogeneity of response in depression.How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.Therapeutic inferences for individual patients.The Range and Scientific Value of Randomized Trials.Exploratory trials, confirmatory observations: a new reasoning model in the era of patient-centered medicine.Who can respond to treatment? Identifying patient characteristics related to heterogeneity of treatment effects.Milbank quarterly.Patients' views about causes and preferences for the management of cancer-related fatigue-a case for non-congruence with the physicians?Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction?The not-so-hidden costs of surgical site infections.N-of-1 trials in the clinical care of patients in developing countries: a systematic review.Complex questions command complex analyses: comparative effectiveness of drug treatment strategies in atrial fibrillation
P2860
Q24288800-A23E27BC-B02F-4247-BD58-074551A9FF94Q24288920-E947B2A9-EB74-48F2-918C-48DF1D082A76Q28393588-55288675-7703-4CE4-816F-D3B343CFC4D4Q31143342-2395FD05-5FCD-4181-9292-9BFEC6720166Q33580392-7D8BAC99-6B73-4218-B178-27BD10B0330EQ33618795-2C52F5F4-46F1-46D5-8723-1C21A42C4C9BQ33963712-0AD92560-6672-4AF3-AF26-4813B1F35B12Q34509675-ACDBD6DC-5372-4DC9-A375-E07E55517EF1Q35098246-829A10F3-0592-4630-9F3E-D307A62519FAQ36054222-58D69483-2CA1-4BAF-9785-162305C1B5ADQ36167006-8DB7B1FE-A764-4E46-BA74-AC3CC87E3312Q36551983-6631B55C-ED0E-4D56-B9DB-9BF1F8633A98Q36748799-30B72A11-54B9-47B1-B89C-4AEE832F5E94Q36910658-24FA7E5C-E4DF-4532-AB9F-2126A5431788Q36993077-C0E0BA96-036C-4D03-BD0E-96E596D01D07Q37022593-E5171762-78B5-4A99-AB1C-26411A624052Q37080658-D9700119-79DE-4E4D-9274-A3B21B855678Q37212198-39CDDC06-52DF-4362-856D-A45DFE1DF07CQ37253011-96BB7E30-BB8D-4FB8-A41D-2C63346D40D0Q37284002-D8939DE6-B01D-41F8-875C-E468B100A25DQ37678444-1E931F2F-B500-47A0-83D8-640AC31FF7A0Q37896168-9F7EBAFC-F6A2-468C-99AC-2600C3EA2615Q38003344-8348A3D0-5755-4DBD-85E4-DDC8E19F2D31Q38068890-4BFF798F-C212-4EBE-BB97-389EA4F94838Q41685481-A13AE964-8195-4592-B392-762D751625BDQ42379773-71FC0E29-1504-4E5D-940B-BF99385B8DFEQ42735839-CD59B097-E999-46B5-9216-373BFD431EFDQ43062167-EA5701AB-554A-4124-A349-703E60EE4751Q43118690-30D3B2F4-CC1C-457D-A7E6-62B654ABC2E9Q44375252-F37B01AD-DEDD-4F95-AB82-FD8510E5639FQ45196767-EDAE6594-ACE5-4E9E-B6C4-42FF1CA529FCQ50941103-BA4B343C-D5FB-42A6-9631-53D3AE36FBBFQ55008394-84FE7FF4-9A48-471F-84F0-DF625A5FAF05Q58665533-CAE1599C-48EC-4946-9F93-6168656844CE
P2860
Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Heterogeneity of treatment eff ...... yment, and quality assessment.
@ast
Heterogeneity of treatment eff ...... yment, and quality assessment.
@en
type
label
Heterogeneity of treatment eff ...... yment, and quality assessment.
@ast
Heterogeneity of treatment eff ...... yment, and quality assessment.
@en
prefLabel
Heterogeneity of treatment eff ...... yment, and quality assessment.
@ast
Heterogeneity of treatment eff ...... yment, and quality assessment.
@en
P1476
Heterogeneity of treatment eff ...... yment, and quality assessment.
@en
P2093
Naihua Duan
Sherrie H Kaplan
P356
10.1016/J.AMJMED.2007.02.002
P407
P433
P577
2007-04-01T00:00:00Z